Centaurus Financial, Inc. Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Centaurus Financial, Inc.

  • $1.44 Billion
  • Q3 2024

A detailed history of Centaurus Financial, Inc. transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Centaurus Financial, Inc. holds 1,440 shares of PPH stock, worth $134,856. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,440
Previous 1,460 1.37%
Holding current value
$134,856
Previous $133,000 2.26%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$90.59 - $99.43 $1,811 - $1,988
-20 Reduced 1.37%
1,440 $136,000
Q2 2024

Sep 20, 2024
BUY
$84.87 - $93.23 $5,940 - $6,526
70 Added 5.04%
1,460 $133,000
Q1 2024

May 14, 2024
BUY
$82.63 - $90.89 $114,855 - $126,337
1,390 New
1,390 $126,000
Q3 2018

Nov 05, 2018
SELL
N/A
-16 Closed
0 $0
Q2 2018

Aug 15, 2018
BUY
N/A
16 New
16 $1,000

Others Institutions Holding PPH

# of Institutions
147
Shares Held
6.02M
Call Options Held
14.5K
Put Options Held
50.1K
View Full List

About VANECK ETF TR VANECK PHARMACEU

PPH Quotes by TradingView
  • Ticker PPH
  • Sector ETFs
  • Industry ETFs
More about PPH
Track This Portfolio

Track Centaurus Financial, Inc. Portfolio

Follow Centaurus Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email